CRIS Current Research Information System

BONIFAZI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.128
NA - Nord America 4.654
EU - Europa 3.997
AF - Africa 374
SA - Sud America 262
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.588
VN - Vietnam 1.919
CN - Cina 1.500
SG - Singapore 1.459
IT - Italia 1.163
GB - Regno Unito 540
SE - Svezia 451
DE - Germania 448
HK - Hong Kong 342
IN - India 248
NL - Olanda 243
KR - Corea 225
FR - Francia 199
FI - Finlandia 180
BR - Brasile 165
RU - Federazione Russa 158
IE - Irlanda 132
UA - Ucraina 128
CI - Costa d'Avorio 113
JP - Giappone 92
TG - Togo 79
AT - Austria 72
ZA - Sudafrica 67
JO - Giordania 57
BG - Bulgaria 52
SC - Seychelles 52
CH - Svizzera 49
AR - Argentina 44
CA - Canada 40
PH - Filippine 39
BE - Belgio 34
ID - Indonesia 32
TH - Thailandia 32
PL - Polonia 26
BD - Bangladesh 25
NG - Nigeria 25
EE - Estonia 24
ES - Italia 24
IQ - Iraq 23
TW - Taiwan 22
TR - Turchia 19
EC - Ecuador 18
MX - Messico 18
PK - Pakistan 18
CL - Cile 16
AU - Australia 14
SA - Arabia Saudita 13
IR - Iran 12
LT - Lituania 12
CO - Colombia 9
KE - Kenya 9
HR - Croazia 8
RO - Romania 8
CZ - Repubblica Ceca 7
EG - Egitto 7
GR - Grecia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
PT - Portogallo 6
RS - Serbia 6
MA - Marocco 5
AZ - Azerbaigian 4
ET - Etiopia 4
LB - Libano 4
NO - Norvegia 4
NP - Nepal 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
KG - Kirghizistan 3
KH - Cambogia 3
MY - Malesia 3
PS - Palestinian Territory 3
BO - Bolivia 2
BY - Bielorussia 2
GE - Georgia 2
GH - Ghana 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
TJ - Tagikistan 2
TZ - Tanzania 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CG - Congo 1
CR - Costa Rica 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MW - Malawi 1
Totale 15.422
Salva come PNG Salva come JPEG
Città #
Singapore 1.044
Ashburn 569
Ho Chi Minh City 505
Chandler 456
Hefei 442
Southend 416
Hanoi 412
Bologna 329
Hong Kong 316
Fairfield 300
San Jose 280
Seoul 202
Ann Arbor 184
Beijing 172
Dong Ket 172
Woodbridge 144
Seattle 139
Wilmington 139
Helsinki 135
Dublin 131
Houston 130
Santa Clara 130
Princeton 119
Abidjan 112
New York 107
Dallas 104
Boardman 103
Los Angeles 90
Cambridge 83
Da Nang 83
Jacksonville 80
Lomé 79
Milan 78
Tokyo 78
Lauterbourg 72
Munich 61
Haiphong 58
Amman 56
Frankfurt am Main 52
Sofia 51
Vienna 49
Berlin 46
Bremen 46
Nanjing 46
Bern 42
Council Bluffs 42
Westminster 40
Bengaluru 39
Buffalo 39
Turin 38
Redondo Beach 34
Rome 34
Brussels 33
Florence 33
Guangzhou 31
Padova 31
Johannesburg 28
Hyderabad 27
Shanghai 27
Biên Hòa 26
London 25
São Paulo 25
Redmond 24
Saint Petersburg 24
San Diego 24
Turku 23
Amsterdam 22
Abeokuta 21
Changsha 21
Hải Dương 21
Nuremberg 21
Can Tho 20
Jakarta 20
Phoenix 20
The Dalles 20
Lappeenranta 19
Brooklyn 18
Jinan 18
Orem 18
Toronto 18
Verona 18
Warsaw 17
Hebei 16
Bangkok 15
Quận Bình Thạnh 15
Reggio Emilia 15
Zhengzhou 15
Castel Maggiore 14
Chicago 14
Mülheim 14
Paris 14
Thái Nguyên 14
Yubileyny 14
San Francisco 13
Vũng Tàu 13
Falkenstein 12
Medford 12
Nanchang 12
New Delhi 12
Shijiazhuang 12
Totale 9.647
Salva come PNG Salva come JPEG
Nome #
Digitisation of temporary exhibitions: the Aldrovandi case 346
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. 342
Longitudinal tear protein changes correlate with ocular chronic gvhd development in allogeneic hematopoietic stem cell transplant patients 301
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 295
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 294
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 272
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 252
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 246
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia 239
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 237
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 235
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! 233
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 228
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 225
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 223
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 222
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 221
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation 218
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. 217
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission. 216
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 216
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 215
Detection of Brain-Derived Cell-Free DNA in Plasma 212
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. 212
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 209
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). 199
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome 199
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 197
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 195
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 194
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 193
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity 193
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease 187
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 186
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 184
GVHD and prognostic factors. 183
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 182
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 181
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 177
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 177
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 175
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation 174
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. 169
Effect on survival of the development of late-onset non-infectious pulmonarycomplications after stem cell transplantation. 167
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 166
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia 165
Stem cell mobilization and collection in patients with liver cirrhosis. 165
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients. 165
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies. 162
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 150
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 149
CMV-RNAemia as new marker of active viral replication in transplant recipients 148
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 148
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 146
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 143
Meibomian Gland Dropout in Hematological Patients Prior to Hematopoietic Stem Cell Transplantation 142
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 141
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 141
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients 139
Conjunctival epithelial cells (CEC) morphology in hematological patients before and after hematopoietic stem cell transplantation (HSCT). A Cytological and Confocal Microscopy Study 136
Epigenetic age acceleration in hematopoietic stem cell transplantation 132
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study 132
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 130
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 123
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 122
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation 120
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 117
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] 117
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study 116
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT) 116
PREDICTIVITY OF TEAR PARAMETERS IN THE ONSET OF OCULAR GRAFT VERSUS HOST DISEASE (GVHD) DRY EYE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). 115
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation 113
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection 113
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas 111
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 111
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy 110
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. 109
Brexucabtagene autoleucel in‐vivo expansion and BTKi refractoriness have a negative influence on progression‐free survival in mantle cell lymphoma: Results from CART‐SIE study 107
Ribosomal DNA instability: An evolutionary conserved fuel for inflammaging 107
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma 104
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient 100
The role of extracellular DNA in COVID-19: Clues from inflamm-aging 96
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 93
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 91
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 90
null 86
null 83
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma 81
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 77
null 75
Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation 66
Correction to: Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review (Journal of Neurology, (2022), 269, 8, (4560-4563), 10.1007/s00415-022-11117-8) 60
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients 59
CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study 47
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma 44
Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study 38
Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study 36
Impact of neurotoxicity and steroid therapy on cancer progression-free survival in lymphoma patients treated with anti-CD19 CAR T cells 33
Prospective observational study of magnetic resonance imaging in anti-CD19 CAR T-cell-associated neurotoxicity 29
Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell and in Solid Organ Transplantation: Updated Recommendations by the GITMO, SITO, SIMIT, and AMCLI Italian Societies. 27
Totale 15.680
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 0 0 0 0 48 57 275
2021/20221.418 78 36 73 152 96 46 49 119 84 143 331 211
2022/20231.931 216 282 106 250 125 151 56 103 301 41 194 106
2023/2024758 56 85 63 105 64 175 25 44 15 38 58 30
2024/20253.042 128 331 233 207 242 157 210 160 80 309 243 742
2025/20266.294 586 814 581 566 579 326 822 267 1.285 468 0 0
Totale 15.731